Randomised controlled trials may underestimate drug effects: balanced placebo trial design.
<h4>Background</h4>It is an inherent assumption in randomised controlled trials that the drug effect can be estimated by subtracting the response during placebo from the response during active drug treatment.<h4>Objective</h4>To test the assumption of additivity. The primary...
Enregistré dans:
Auteurs principaux: | Karen Lund, Lene Vase, Gitte L Petersen, Troels S Jensen, Nanna B Finnerup |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3fe231dc7d28486780cd6b4e6322fc7f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical use of pregabalin in the management of central neuropathic pain
par: Nanna B Finnerup, et autres
Publié: (2007) -
Polymorphism in serotonin receptor 3B is associated with pain catastrophizing.
par: Emilia Horjales-Araujo, et autres
Publié: (2013) -
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
par: Clive Ballard, et autres
Publié: (2008) -
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
par: Chris Fox, et autres
Publié: (2012) -
A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.
par: Lakkhina Troeung, et autres
Publié: (2013)